Showing results (731-740 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|October 27, 2023
The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtypeMaria Fala, Susana Ros, Ashley Sawle, et al.
Neuro-Oncology Advances|October 16, 2023
The value of arterial spin labelling (ASL) perfusion MRI in the assessment of post-treatment progression in adult glioma: A systematic review and meta-analysisTamadur A Alsulami, Harpreet Hyare, David L Thomas, et al.
Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.
Neuro-Oncology Advances|October 9, 2023
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022Christoph Oster, Teresa Schmidt, Sarina Agkatsev, et al.
Neuro-Oncology Advances|October 23, 2023
Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort studyLine Sagerup Bjorland, Rupavathana Mahesparan, Øystein Fluge, et al.
Neuro-Oncology Advances|September 29, 2023
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastomaMame Daro Faye, Jacob Easaw, Paula De Robles, et al.
Neuro-Oncology Advances|September 25, 2023
Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastomaRyutaro Makino, Nayuta Higa, Toshiaki Akahane, et al.
Neuro-Oncology Advances|September 18, 2023
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods studyAmeeta Retzer, Elin Baddeley, Stephanie Sivell, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Neuro-Oncology Advances|June 26, 2023
Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomesDavid A DeVries, Terence Tang, Ghada Alqaidy, et al.
Pageof 134